Intraocular Pressure Elevation after Injection of Triamcinolone Acetonide: A Multicenter Retrospective Case-Control Study

American Journal of Ophthalmology

Volumn 145, Issue 4, 2008, Pages

  Inatani, Masaru ^a   Iwao, Keiichiro ^a   Kawaji, Takahiro ^a   Hirano, Yoshio ^b   Ogura, Yuichiro ^b   Hirooka, Kazuyuki ^c   Shiraga, Fumio ^c   Nakanishi, Yoriko ^d   Yamamoto, Hiroyuki ^d   Negi, Akira ^d   Shimonagano, Yuka ^e   Sakamoto, Taiji ^e   Shima, Chieko ^f   Matsumura, Miyo ^f   Tanihara, Hidenobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

^d KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e KAGOSHIMA UNIVERSITY   (Japan)

^f KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; AGE; AGED; ARTICLE; CASE CONTROL STUDY; CATARACT; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC RETINOPATHY; DRUG DOSE; FEMALE; HUMAN; HYPERTENSION; INTRAOCULAR PRESSURE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RETINA DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; RISK FACTOR; SIDE EFFECT; STATISTICAL ANALYSIS; SUBRETINAL NEOVASCULARIZATION; TONOMETRY;

EID: 40849113033     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.12.010     Document Type: Article

References (24)

1. Jonas J.B., Kreissig I., and Degenring R. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases. Prog Retin Eye Res 24 (2005) 587-611
2. Kawaji T., Hirata A., Awai N., et al. Trans-tenon retrobulbar triamcinolone injection for macular edema associated with branch retinal vein occlusion remaining after vitrectomy. Am J Ophthalmol 140 (2005) 540-542
3. Antcliff R.J., Spalton D.J., Stanford M.R., Graham E.M., Ffytche T.J., and Marshall J. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 108 (2001) 765-772
4. Danis R.P., Ciulla T.A., Pratt L.M., and Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 20 (2000) 244-250
5. Greenberg P.B., Martidis A., Rogers A.H., Duker J.S., and Reichel E. Intravitreal triamcinolone acetonide for macular edema due to central retinal vein occlusion. Br J Ophthalmol 86 (2002) 247-248
6. Smithen L.M., Ober M.D., Maranan L., and Spaide R.F. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 138 (2004) 740-743
7. Jonas J.B., Kreissig I., and Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 87 (2003) 24-27
8. Jea S.Y., Byon I.S., and Oum B.S. Triamcinolone-induced intraocular pressure elevation: intravitreal injection for macular edema and posterior subtenon injection for uveitis. Korean J Ophthalmol 20 (2006) 99-103
9. Benz M.S., Albini T.A., Holz E.R., et al. Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide. Ophthalmology 113 (2006) 1174-1178
10. Ozkiris A., and Erkilic K. Complications of intravitreal injection of triamcinolone acetonide. Can J Ophthalmol 40 (2005) 63-68
11. Yamashita T., Uemura A., Kita H., and Sakamoto T. Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema. J Glaucoma 16 (2007) 220-224
12. Rhee D.J., Peck R.E., Belmont J., et al. Intraocular pressure alterations following intravitreal triamcinolone acetonide. Br J Ophthalmol 90 (2006) 999-1003
13. Hirooka K., Shiraga F., Tanaka S., Baba T., and Mandai H. Risk factors for elevated intraocular pressure after trans-tenon retrobulbar injections of triamcinolone. Jpn J Ophthalmol 50 (2006) 235-238
14. Kaushik S., Gupta V., Gupta A., Dogra M.R., and Singh R. Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion. Am J Ophthalmol 137 (2004) 758-760
15. Iwao K., Inatani M., Kawaji T., Koga T., Mawatari Y., and Tanihara H. Frequency and risk factors for intraocular pressure elevation after posterior sub-Tenon capsule triamcinolone acetonide injection. J Glaucoma 16 (2007) 251-256
16. Bakri S.J., and Beer P.M. The effect of intravitreal triamcinolone acetonide on intraocular pressure. Ophthalmic Surg Lasers Imaging 34 (2003) 386-390
17. Gillies M.C., Simpson J.M., Billson F.A., et al. Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch Ophthalmol 122 (2004) 336-340
18. Park C.H., Jaffe G.J., and Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 136 (2003) 419-425
19. Massin P., Audren F., Haouchine B., et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 111 (2004) 218-224
20. Park H.Y., Yi K., and Kim H.K. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Korean J Ophthalmol 19 (2005) 122-127
21. Becker B., Bresnick G., Chevrette L., Kolker A.E., Oaks M.C., and Cibis A. Intraocular pressure and its response to topical corticosteroids in diabetes. Arch Ophthalmol 76 (1966) 477-483
22. Palmberg P. Screening for diabetic retinopathy. Diabetes Care 24 (2001) 419-420
23. Honjo M., Tanihara H., Inatani M., and Honda Y. External trabeculotomy for the treatment of steroid-induced glaucoma. J Glaucoma 9 (2000) 483-485
24. Jonas J.B., Degenring R., Kreissig I., and Akkoyun I. Safety of intravitreal high-dose reinjections of triamcinolone acetonide. Am J Ophthalmol 138 (2004) 1054-1055